Monoclonal Antibodies Partnering Terms and Agreements - 0 views
-
Bharatbookbureau MarketReport on 07 Jun 13The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.